Arcus Biosciences to Participate in Two Upcoming Investor Conferences
February 28 2024 - 3:05PM
Business Wire
Arcus Biosciences (NYSE:RCUS), a clinical-stage, global
biopharmaceutical company focused on developing differentiated
molecules and combination therapies for people with cancer,
announced that its management team will participate in the
following upcoming investor conferences in March:
Leerink Global Biopharma Conference
2024 Date: Monday, March 11th, 2024 at 4:00 p.m. ET Location:
Miami Beach, FL Format: Fireside Chat
Barclays 26th Annual Global Healthcare
Conference Date: Tuesday, March 12th, 2024 at 2:35 p.m. ET
Location: Miami Beach, FL Format: Fireside Chat
Live webcasts of the fireside chats and panel will be available
by visiting the “Investors & Media” section of the Arcus
Biosciences website at www.arcusbio.com. Replays will be available
following each live event.
About Arcus Biosciences
Arcus Biosciences is a clinical-stage, global biopharmaceutical
company developing differentiated molecules and combination
medicines for people with cancer. In partnership with industry
partners, patients and physicians around the world, Arcus is
expediting the development of first- or best-in-class medicines
against well-characterized biological targets and pathways and
studying novel, biology-driven combinations that have the potential
to help people with cancer live longer. Founded in 2015, the
company has expedited the development of multiple investigational
medicines into clinical studies, including new combination
approaches that target TIGIT, PD-1, the adenosine axis (CD73, dual
A2a/A2b receptor and CD39), AXL and HIF-2a. For more information
about Arcus Biosciences’ clinical and pre-clinical programs, please
visit www.arcusbio.com or follow us on X.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240227559746/en/
Investor Inquiries Pia Eaves VP of Investor Relations
& Strategy (617) 459-2006 peaves@arcusbio.com
Media Inquiries Holli Kolkey VP of Corporate
Communications (650) 922-1269 hkolkey@arcusbio.com
Arcus Biosciences (NYSE:RCUS)
Historical Stock Chart
From Jan 2025 to Feb 2025
Arcus Biosciences (NYSE:RCUS)
Historical Stock Chart
From Feb 2024 to Feb 2025